Ms. Ananya Das, currently serving as a CSIR-Senior Research Fellow at Chittaranjan
National Cancer Institute in Kolkata, India, has garnered the prestigious "Asia's Best
Researcher Award" for " Understanding the immunological aspects of SARS-CoV-2 causing
COVID-19 pandemic: A therapeutic approach ". Ms. Das has dedicated the past five years to
the field of immunology, embarking on her academic journey by earning her undergraduate
degree in Zoology from Gurudas College at the University of Calcutta, India. Her academic
pursuits fostered a burgeoning interest in immunology, leading her to pursue a Master's
degree in Zoology from the same university. During her Master's program, Ms. Das actively
participated in scientific events such as Bioscope 2018 and Bioscope 2019, where she
presented research posters, and engaged in various scientific workshops. In 2019, her
dedication to the field culminated in her successful qualification for the CSIR-UGC National
Eligibility Test (NET) examination, securing an impressive All India Rank (AIR) of 149.
Subsequently, she commenced her journey as a Junior Research Fellow at Chittaranjan
National Cancer Institute in Kolkata, where she diligently delved into tumor immunology,
specifically focusing on the intricate interplay of immune cells within the tumor
microenvironment of breast cancer. Her current research canters on unravelling the
macrophage paradigm in breast cancer. Ms. Das's commitment to advancing scientific
knowledge is evident through her significant contributions, including four research articles
and two review articles, all co-authored with fellow researchers. Additionally, she has a
conference proceeding to her credit, presented at the American Association of Cancer
Research (AACR) in 2021 and FASEB in the same year. In 2022, her dedication was further
acknowledged with the receipt of the Best Poster Award during National Science Day at
Chittaranjan National Cancer Institute on February 28, 2022. She also actively participated in
a poster presentation at the 42nd Annual Conference of the Indian Association for Cancer
Research in 2022. Ms. Das's remarkable journey from an enthusiastic young biologist to a
pioneering researcher in tumor immunology exemplifies her unwavering pursuit of
knowledge and her deep-seated desire to make a meaningful impact on the lives of
individuals affected by cancer.